Home › Funds › Defilade Capital Management, L.P. › GMED

Defilade Capital Management, L.P. position in GMED

GLOBUS MED INC · Health Care

Defilade Capital Management, L.P. reported holding 139,637 shares of GMED (GLOBUS MED INC) in its Q2 2026 13F filing — a position valued at US$11.0M, representing 1.48% of its reported portfolio and ranking #28 among its reported holdings. Defilade Capital Management, L.P. has disclosed GMED holdings in 3 of the last 3 reported quarters, going back to Q4 2025.

Latest position (Q2 2026)139.64K sh
Reported value held$11.03M
Portfolio Weight1.48%
First reportedQ4 2025
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Defilade Capital Management, L.P.'s GMED position evolved

Defilade Capital Management, L.P. first disclosed a stake in GMED in Q4 2025 at 267,212 shares (US$23.3M). The position peaked in Q1 2026 at 354,350 shares, worth US$30.5M. Across 3 filings, Defilade Capital Management, L.P. increased the stake 1 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 139,637 shares valued at US$11.0M — a reduction of -214,713 shares quarter over quarter.. Notable position changes include a 33% increase in Q1 2026 (shares fell 8% over the following quarter), a 61% trim in Q2 2026 (shares fell 5% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2025 267.21K $23.33M New
Q1 2026 354.35K $30.53M Add
Q2 2026 139.64K $11.03M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About GMED and 13F data

GMED (GLOBUS MED INC) is a Health Care company. 39 other funds we track also report a position in GMED — the largest reported positions include KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC (US$338.1M), Sculptor Capital LP (US$237.0M), Boston Trust Walden Corp (US$124.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding GMED

All GMED fund holders →

FAQ

How long has Defilade Capital Management, L.P. held GMED?

Defilade Capital Management, L.P. has disclosed GMED holdings in 3 of the last 3 reported quarters, going back to Q4 2025.

What is Defilade Capital Management, L.P.'s current position in GMED?

As of Q2 2026, Defilade Capital Management, L.P. holds 139.64K shares of GMED (GLOBUS MED INC), valued at $11.03M, representing 1.48% of its reported portfolio and ranking #28.

Has Defilade Capital Management, L.P. been buying or selling GMED?

In the latest 13F filing (Q2 2026), Defilade Capital Management, L.P. reduced its position in GMED. The position peaked in Q1 2026 at 354.35K shares.

Which other funds hold GMED?

Other major institutional holders of GMED include KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC, Sculptor Capital LP, Boston Trust Walden Corp, among 39 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.